"Biomodel Organism" Holds Ceremony in Beijing to Celebrate Listing on NEEQ


On November 18, 2016, Shanghai Model Organisms Center, Inc. was listed on the NEEQ as follows. Stock Name: Biomodel Organism; Stock Code: 839728.


 On December 5, 2016, the company held a ceremony in Beijing to celebrate its listing on NEEQ. It was attended by stockholder representatives including Mr. Sun Zhigang, Director of Post-Investments at IDG Capital, Mr. Zhou Reqing from Shanghai Technology Venture Capital Co., Ltd., Mr. Liu Yuqi, Deputy General Manager of Shanghai Zhangjiang Collective Asset Management and Investment Management Ltd., Mr. Wang Keqiang from Sealand Securities Co., Ltd., Mr. Wang Jimin from Asia Pacific (Group) CPAs, and Mr. Cao Zongsheng from AllBright Law Offices. The occasion marking the company's entrance into capital markets was also witnessed by the company's Chairman, Fei Jian, General Manager, Wang Mingjun, Deputy General Manager, Kuang Ying, and Finance Manager, Qiang Yiwei. 


On behalf of the company, Mr. Fei Jian, Chairman, gave a speech and rang the market opening bell. During his speech, Mr. Fei expressed his gratitude to the company's stockholders for their support and regard for the company's growth over the sixteen years. He also extended his sincere appreciation to the expert and efficient support of dealer, accounting, legal, and valuation firms for this change in stockholding framework and NEEQ-listing. Mr. Fei also thanked the company's management team and employees for their efforts and contributions to the company. He said that the company has always upheld its philosophy of innovation in technology, as well as professionalism and pragmatism. The company has stayed at the forefront of industry developments, and this NEEQ-listing opens doors to capital markets for the company, which he believed would enable the company to achieve greater heights, with the strong support of its various stockholders and employees.


Symbolizing the company's entrance into capital markets, the ringing of the bell signifies it has become a public company. This has built a vast platform for the company to grow further, while providing it with new opportunities for achieving greater business performance and assuming more social responsibilities. We will continue to focus ourselves on high quality, efficiency, and practical results. By harnessing our innovation and efforts, we will lead the healthy development of the industry.



You may also like

Shanghai Model Organisms Center Inc has licensed CRISPR-Cas9 technology from Broad Institute

On Dec 16, 2018, Broad Institute and Shanghai Model Organisms Center Inc (SMOC) has entered into a non-exclusive license agreement under which Broad has granted SMOC worldwide rights to commercialize a service platform for genetically modified mouse models under Broad's intellectual property.

Learn more
Customizing Mouse Models: Delivering in 100 Days to Speed Up Your Research!

At GenoBioTX, we understand that the lengthy wait times for gene-modified mouse models can hinder your research progress. Traditional methods often require 6-9 months, leading to delays and increased costs. That’s why we’re thrilled to introduce our innovative service designed to streamline this process and deliver results faster.

Learn more